Literature DB >> 18294560

Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications.

Albert L Waldo1, Gregory K Feld.   

Abstract

There is a close interrelationship between atrial fibrillation (AF) and atrial flutter (AFL). Atrial fibrillation of variable duration precedes the onset of AFL in almost all instances; during AF, the functional components needed to complete the AFL re-entrant circuit, principally a line of block (LoB) between the vena cavae, are formed; if this LoB does not form, classical AFL does not develop. In contrast, there seems to be a spectrum of atrial re-entrant circuits (drivers) of short cycle lengths (CLs) (i.e., AFL). When the CL of the AFL re-entrant circuit is so short that it will only activate portions of the atria in a 1:1 manner, the rest of the atria will be activated rapidly but irregularly (i.e., via fibrillatory conduction), resulting in AF. In short, there are probably several mechanisms of AF, 1 of which is due to a very rapid AFL causing fibrillatory conduction. All of these interactions of AF and AFL have important clinical implications.

Entities:  

Mesh:

Year:  2008        PMID: 18294560     DOI: 10.1016/j.jacc.2007.08.066

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  43 in total

1.  Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification.

Authors:  Jun Wang; Elzbieta Klysik; Subeena Sood; Randy L Johnson; Xander H T Wehrens; James F Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Clinical mapping approach to diagnose electrical rotors and focal impulse sources for human atrial fibrillation.

Authors:  Sanjiv M Narayan; David E Krummen; Wouter-Jan Rappel
Journal:  J Cardiovasc Electrophysiol       Date:  2012-04-26

3.  Clinical application of pacemakers in atrial tachyarrhythmias.

Authors:  W G de Voogt; N M van Hemel
Journal:  Neth Heart J       Date:  2008-10       Impact factor: 2.380

4.  Risk of atrial fibrillation, stroke, and death after radiofrequency catheter ablation of typical atrial flutter.

Authors:  Javier García Seara; Sergio Raposeiras Roubin; Francisco Gude Sampedro; Vanessa Balboa Barreiro; José Martínez Sande; Moisés Rodriguez Mañero; Pilar Cabans Grandio; Belen Alvarez; José González Juanatey
Journal:  Clin Res Cardiol       Date:  2014-02-25       Impact factor: 5.460

5.  Atrial flutter: A smoking gun for atrial fibrillation.

Authors:  Javier E Banchs
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-17

6.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  Circulation       Date:  2014-03-28       Impact factor: 29.690

Review 7.  Atrial Septal Defect and Atrial Fibrillation: The Known and Unknown.

Authors:  George E Blake; Dhanunjaya Lakkireddy
Journal:  J Atr Fibrillation       Date:  2008-09-16

8.  GIANT Flutter Waves in ECG Lead V1: a Marker of Pulmonary Hypertension.

Authors:  James A Reiffel
Journal:  J Atr Fibrillation       Date:  2008-09-16

9.  Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity.

Authors:  J Gustav Smith; Pyotr G Platonov; Bo Hedblad; Gunnar Engström; Olle Melander
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

10.  Efficacy and safety of dofetilide in patients with atrial fibrillation and atrial flutter.

Authors:  Javier E Banchs; Deborah L Wolbrette; Soraya M Samii; Erica D Penny-Peterson; Parag P Patel; Sallie K Young; Mario D Gonzalez; Gerald V Naccarelli
Journal:  J Interv Card Electrophysiol       Date:  2008-08-08       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.